Drug discovery strategies: technologies to accelerate translation from target to drug.
MetadataShow full item record
The development of new molecular therapeutics for cancer treatment is based on the identification of molecular abnormalities that drive the malignant process. The discovery of novel molecular targets is made quicker and more efficient by use of powerful high throughput technologies such as genome sequencing and gene expression microarrays. Similarly, the drug discovery process is being accelerated by a range of other valuable technologies. Using these approaches, we can expect to see a range of personalised molecular therapeutics becoming available for cancer treatment.
License start date
Journal of chemotherapy (Florence, Italy), 2004, 16 Suppl 4 pp. 13 - 15